Maternal smoking during pregnancy and cortical structure in children with attention-deficit/hyperactivity disorder.

ADHD Children Cortical surface area Epigenetic markers Prenatal smoking

Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 18 01 2023
revised: 28 01 2024
accepted: 11 02 2024
pubmed: 18 2 2024
medline: 18 2 2024
entrez: 17 2 2024
Statut: ppublish

Résumé

Maternal smoking during pregnancy (MSDP) is considered a risk factor for ADHD. While the mechanisms underlying this association are not well understood, MSDP may impact the developing brain in ways that lead to ADHD. Here, we investigated the effect of prenatal smoking exposure on cortical brain structures in children with ADHD using two methods of assessing prenatal exposure: maternal recall and epigenetic typing. Exposure groups were defined according to: (1) maternal recall (+MSDP: n = 24; -MSDP: n = 85) and (2) epigenetic markers (EM) (+EM: n = 14 -EM: n = 21). CIVET-1.1.12 and RMINC were used to acquire cortical brain measurements and perform statistical analyses, respectively. The vertex with highest significance was tested for association with Continuous Performance Test (CPT) dimensions. While no differences of brain structures were identified between +MSDP and -MSDP, +EM children (n = 10) had significantly smaller surface area in the right orbitofrontal cortex (ROFc), middle temporal cortex (RTc) and parahippocampal gyrus (RPHg) (15% FDR) compared to -EM children (n = 20). Cortical surface area in the RPHg significantly correlated with CPT commission errors T-scores. This study suggests that molecular markers may better define exposure to environmental risks, as compared to human recall.

Identifiants

pubmed: 38367455
pii: S0165-1781(24)00076-3
doi: 10.1016/j.psychres.2024.115791
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115791

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr B. Chaumette has received research funding from the foundation Bettencourt Schueller, speaking fees from Janssen-Cilag, Lundbeck, and Eisai outside the submitted work. Dr N. Grizenko is a member of the advisory board of Purdue and Shire. Dr R. Joober is on the advisory boards and speakers’ bureaus of Pfizer, Janssen, Ortho, BMS, Sunovion, Otsuka, Lundbeck, Perdue and Myelin. He has received grant funding from them and from AstraZeneca and HLS. He has received honoraria from Janssen Canada, Shire, Lundbeck, Otsuka, Pfizer, and from Perdue for CME presentations and royalties for Henry Stewart talks. The other authors report no biomedical financial interests nor potential conflicts of interest.

Auteurs

Nellie H Fotopoulos (NH)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Human Genetics, McGill University, Montréal, Québec, Canada.

Boris Chaumette (B)

Department of Psychiatry, McGill University, Montréal, Québec, Canada; Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, GHU-Paris Psychiatrie et Neurosciences, Paris, France.

Gabriel A Devenyi (GA)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada.

Sherif Karama (S)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Montréal Neurological Institute, Montréal, Québec, Canada.

Mallar Chakravarty (M)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Biological and Biomedical Engineering, McGill University, Montréal, Québec, Canada.

Aurelie Labbe (A)

Department of Decision Sciences, HEC Montreal, Montréal, Québec, Canada.

Natalie Grizenko (N)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada.

Norbert Schmitz (N)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada.

Weam Fageera (W)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Human Genetics, McGill University, Montréal, Québec, Canada.

Ridha Joober (R)

Douglas Mental Health University Institute, Montréal, Québec, Canada; Department of Human Genetics, McGill University, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada. Electronic address: ridha.joober@douglas.mcgill.ca.

Classifications MeSH